Hereditary characteristics of the S339L mutation in a patient with maple syrup urine disease in Vietnam
Authors
DOI: https://doi.org/10.15625/2615-9023/v42n2.14913Keywords:
BCKAD, BCKDHB, MSUD, S339L, whole exome sequencing.References
Ali E. Z., Ngu L. H., 2018. Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population. Mol. Genet. Metab. Ref., 17: 22−30.
Bashyam M. D., Chaudhary A. K., Sinha M., Nagarajaram H. A., Devi A. R. R., Bashyam L., Reddy E., Dalal A., 2012. Molecular genetic analysis of MSUD from India reveals mutations causing altered protein truncation affecting the C-termini of E1α and E1β. J. Cell Biochem., 113(10): 3122−3132.
Blackburn P. R., Gass J. M., Pinto E., Vairo F., Farnham K. M., Atwal H. K., Macklin S., Klee E., Atwal P. S., 2017. Maple syrup urine disease: mechanisms and management. Appl. Clin. Genet., 10: 57−66.
Deepti G., Sunita B. M., Renu S., Sudha K., Ratna D. P., Jyotsna V., Thomas E., Yosuke S., Seiji Y., Roumi D., Ishwar C. V., 2015. Identification of mutations, genotype-phenotype correlation and prenatal diagnosis of maple syrup urine disease in Indian patients. Eur. J. Med. Genet., 58: 471–478.
Guo Y., Liming L., Jiang L., 2015. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease. Metab. Brain Dis., 30(6): 1395−1400.
Jaafar N., Moleirinho A., Kerkeni E., Monastiri K., Seboui H., Amorim A., Prata M., Quental S., 2013. Molecular characterization of maple syrup urine disease patients from Tunisia. Gene, 517(1): 116−119.
Kerstin G., Ali D., Turgay C., Serap H. K. S., Gülden F. G., Mübeccel D., Oliver F., Udo W., 2009. Molecular genetics of maple syrup urine disease in the Turkish population. Turk. J. Pediatr., 51: 97−102.
Lee J. Y., Chiong M. A., Estrada S. C., Cutiongco-De La Paz E. M., Silao C. L. T., Padilla C. D., 2008. Maple syrup urine disease (MSUD) - Clinical profile of 47 Filipino patients. J. Inherit. Metab. Dis., 31 (Suppl.2).
Nellis M. M., Danner D. J., 2001. Gene preference in maple syrup urine disease. Am. J. Hum. Genet., 68: 232−237.
Skvorak K. J., 2009. Animal models of maple syrup urine disease. J. Inherit. Metab. Dis., 229−246.
Theodoros G., Jacinta L. C., Max W. R., Goula S., Mark K., David T. C., Anthi D., 2009. Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit. Genet. Test Mol. Biomark., 13: 657−664.
Wynn R. M., Chuang J. L., Sansaricq C., Mandel H., Chuang D. T., 2001. Biochemical basis of type Ib (E1β) mutations in maple syrup urine disease. A prevalent allele in patients from the druze kindred in Israel. J. Biol. Chem., 276(39): 36550–36556.
Zhang B., Kuntz M. J., Goodwin G. W., Edenberg H. J., Crabb D. W., Harris., Ramzan H. K., 1989. cDNA cloning of the E1 alpha subunit of the branched chain alpha-keto acid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease. Ann. NY Acad. Sci., 573: 130−136.
Downloads
Metrics
Downloads
PDF Downloaded: 193